Home » Market Analysis » Equity » Ultra Investment 14 | Buy
Ultra Investment 14 | Buy
Investment at a glance
● the stock belongs to Pharma sector
● expected return 22 - 28% in 2 - 3 Months
● average profit ₹25,500/Lakh capital investment
🔒 This is a premium advice for Ultra Subscribers only. Likewise past Ultra Investment recommendations, the post will be unlocked once the Target / StopLoss hit for this stock.
MONEY MANAGEMENT AND INVESTING RULES
1) It’s advisable not to enter/exit beyond the recommended range.2) Diversify capital into our other investment recommendations.3) Risk only the money what you can afford to lose. Hedge accordingly.
The research analysis is prepared by Arijit Banerjee, CMT, CFTe. He is a veteran trader and an active investor having in-depth knowledge in financial market research, advanced technical analysis, market cycle, algorithmic trading and portfolio management. Arijit is a Chartered Market Technician (CMT) accredited by CMT Association USA, the leading global authority of Technical Analysis and has been honoured by Certified Financial Technician (CFTe) from the International Federation of Technical Analysts, USA. SEBI, the regulatory body of Indian financial market also recognizes him as a Research Analyst (INH300006582).
The views expressed herein are based solely on information available publicly/internal data/other sources believed to be reliable, but is not necessarily all-inclusive and is not guaranteed as to accuracy. The recommendations provided herein is solely for informational purposes and are not intended to be and must not be taken alone as the basis for an investment/trading decision. Trading and investing are subject to market risk and the securities discussed and opinions expressed herein may not be suitable for all investors. To read the full disclosure, please click here.
* referred calendar months here e.g. Jan 20, 2020 — July 20, 2020
We respect your privacy.
see all >